Skip Navigation
  • Text Size: A A A
  • Print
  • Email
  • Facebook
  • Tweet
  • Share
  • Print
  • Email
  • Facebook
  • Tweet
  • Share

Division of Blood and Tissue Safety and Availability

Blood and Tissue Safety and Availability

Ensuring that safe blood and tissue products are available when they are needed is important to the health and wellbeing of Americans. The Office of HIV/AIDS and Infectious Disease Policy coordinates HHS activities related to blood and tissue safety and availability, including actions to address the effects of emerging infections such as Zika and Chikungunya on the safety and availability of blood and tissue products. Activities include support for the Advisory Committee on Blood and Tissue Safety and Availability, coordination of activities across HHS agencies, and research to assess the screening, collection, utilization, and availability of blood and tissue products.

U.S. Public Health Service logoAdvisory Committee on Blood and Tissue Safety and Availability (ACBTSA)

Recent ACBTSA Meetings

  • November 9 & 10, 2015
    VHA National Conference Center
    2011 Crystal Drive
    Crystal City, Virginia 22202

Future ACBTSA Meetings

  • “To Be Announced”

Publications & Documents

2012

  • Request for Information (RFI) on Design of a Pilot Operational Study To Assess Alternative Blood Donor Deferral Criteria for Men Who Have Had Sex With Other Men (MSM)  Federal Register Notice

2011

Advisory Committees of Interest to Blood, Cell, Tissues, and Organs

Food and Drug Administration

Blood Stem Cell Transplantation


Content created by Assistant Secretary for Health - Adv. Com./Blood/Tissue Safety
Content last reviewed on April 29, 2016